Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 950 | N/A |
| Receivables | N/A | N/A | N/A | 3,960 | N/A |
| Inventories | N/A | N/A | N/A | 1,650 | N/A |
| Other current assets | 0 | 0 | 0 | 580 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $7,140 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 770 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 2,950 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $3,720 | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $11,980 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 80 | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 2,320 | 0 |
| Other current liabilities | N/A | N/A | N/A | 1,050 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $4,310 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 140 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 5,630 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $5,770 | $N/A |
| Total Liabilities | $N/A | $N/A | $N/A | $10,080 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 100 | N/A |
| Retained earnings | N/A | N/A | N/A | -21,260 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | -200 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $1,900 | $N/A |
| Total Liabilities And Equity | $0 | $0 | $0 | $11,980 | $0 |